Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy

Kidney International

Volumn 54, Issue 3, 1998, Pages 889-896

  Smith, A C ^a   Toto, R ^a   Bakris, G L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Albuminuria; And nephropathy; Dextran clearance; Diabetes; Glomerular filtration rate; Hypertension; Proteinuria

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; IMMUNOGLOBULIN G; NIFEDIPINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY PLASMA FLOW; MALE; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; PROTEINURIA;

EID: 0031657216     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00055.x     Document Type: Article

References (39)

1. L.A. Hebert R.P. Bain D. Verme D. Cattran F.C. Whittier N. Tolchin R.D. Rohde E.J. Lewis for the Collaborative Study Group Remission of nephrotic range proteinuria in type I diabetes Kidney Int 46 1994 1688 1693
2. G.L. Bakris Microalbuminuria: Prognostic implications Curr Opin Nephrol Hypertens 7 1996 219 223
3. H.H. Parving U.M. Smidt E. Hommel Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy Am J Kidney Dis 22 1993 188 195
4. J.E. Heeg P.E. deJong G.K. van der Hem D. de Zeeuw Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril Kidney Int 36 1989 272 279
5. R.T. Gansevoort D. de Zeeuw S. Shahinfar A. Redfield P.E. de Jong Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease J Hypertens 12 Suppl 2 1994 S37 S42
6. G.L. Bakris A.C. Smith Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists Ann Intern Med 125 1996 201 203
7. G.L. Bakris M.R. Weir Salt intake and reductions in arterial pressure and proteinuria: Is there a direct link? Am J Hypertens 9 1996 200S 206S
8. G.L. Bakris J.B. Copley N. Vicknair R. Sadler S. Leurgans Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy Kidney Int 50 1996 1641 1650
9. G.L. Bakris A. Mangrum J.B. Copley N. Vicknair R. Sadler Calcium channel or beta blockade on progression of diabetic renal disease in African-Americans Hypertension 29 1997 743 750
10. K. Abbott A.C. Smith G.L. Bakris Effects of dihydropyridine calcium antagonists on albuminuria in diabetic subjects J Clin Pharmacol 36 1996 274 279
11. G. Remuzzi P. Ruggenenti A. Benigni Understanding the nature of renal disease progression Kidney Int 51 1997 2 15
12. P. Rossing L. Tarnow S. Boelskifte B.R. Jensen F.S. Nielsen H.H. Parving Differences between nisoldipine and lisinopril in GFRs and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment Diabetes 46 1997 481 487
13. M. Velussi E. Brocco F. Frigato M. Zolli B. Muollo M. Maioli A. Carraro G. Tonolo Cernigoi A. Fresu P. Fioretto R. Nosadini Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients Diabetes 45 1996 216 222
14. N. Tarif G.L. Bakris Preservation of renal function: the spectrum of effects by calcium channel blockers Nephrol Dial Transplant 12 1997 2244 2250
15. A.P. Rocchini V. Katch D. Kveselis C. Moorehead M.N. Maring R. Lampamn M. Gregory Insulin and renal sodium retention in obese adolescents Hypertension 14 1989 367 374
16. S.E. Warren D.T. O'Connor I.M. Cohen J.A. Mitas Renal hemodynamic changes during long-term antihypertensive therapy Clin Pharmacol Ther 29 1981 310 317
17. H.C. Mitchell R.D. Smith P.A. Cutler D. Sica J. Videon S. Thompson-Bell K. Jone C. Bradley-Guidry R.D. Toto Racial differences in the renal response to blood pressure lowering during chronic angiotensin converting enzyme inhibition: A prospective, double-blind randomized comparison of fosinopril and lisinopril in older hypertensives with mild to moderate renal insufficiency Am J Kidney Dis 29 1997 897 907
18. A.Y.M. Chan Cheng MLL L.C. Keil B.D. Myers Functional response of healthy and diseased glomeruli to a large, protein-rich meal J Clin Invest 81 1998 245 254
19. A. Hartmann K. Lund H. Holdasas P. Fauchald A. Reisaeter K.J. Berg Contrasting short term effects of nifedipine on glomerular and tubular functions in glomerulonephritic patients J Am Soc Nephrol 5 1994 1385 1390
20. P. August T. Lenz J.H. Laragh Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure Am J Hypertens 6 1993 148S 154S
21. K. Abbott A.C. Smith G.L. Bakris Effects of dihydropyridine calcium antagonists on albuminuria in diabetic subjects J Clin Pharmacol 36 1996 274 279
22. Y. Nakamura B.D. Myers Charge selectivity of proteinuria in diabetic glomerulopathy Diabetes 37 1989 1202 1211
23. M.C. Drumond B. Kristal B.D. Myers W.M. Deen Structural basis for reduced glomerular filtration capacity in nephrotic humans J Clin Invest 94 1994 1187 1195
24. L. Moscorie A. Remuzzi P. Ruggenenti F. Sangalli V. Gamara G. Remuzzi Glomerular size-selective dysfunction is not ameliorated by ACE inhibition and Ca channel blockade. (abstract) J Am Soc Nephrol 7 1996 1362
25. P. Rossing E. Hommel U.M. Smidt H.H. Parving Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment Diabetologia 37 1994 511 516
26. P. Zucchelli A. Zuccala M. Borghi M. Fusaroli M. Sasdelli C. Stallone G. Sanna R. Gaggi Long-term comparison between captopril and nifedipine in the progression of renal insufficiency Kidney Int 42 1992 452 458
27. S. Anderson H.G. Rennke B.M. Brenner Nifedipine versus fosinopril in uninephrectomized diabetic rats Kidney Int 41 1992 891 897
28. P.K. Carmines L.G. Navar Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II Am J Physiol 256 6 Pt 2 1989 F1015 F1020
29. 2+] in renal arterioles Am J Physiol 265 5 Pt 2 1993 F677 F685
30. S.A. Brown C.L. Walton P. Crawford G.L. Bakris Long-term effects of different antihypertensive regimens on renal hemodynamics and proteinuria Kidney Int 43 1993 1210 1218
31. S. Anderson Renal hemodynamics of calcium antagonists in rats with reduced renal mass Hypertension 17 1991 288 295
32. L.D. Dworkin J.A. Benstein E. Tolbert H.D. Feiner Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease J Am Soc Nephrol 7 1996 437 442
33. J.J. Dillon The quantitative relationship between treated blood pressure and progression of diabetic renal disease Am J Kidney Dis 22 1993 798 802
34. R. Toto H.C. Mitchell R.D. Smith H.C. Lee D. McIntire W.A. Pettinger “Strict” blood pressure control and progression of renal disease in hypertensive nephrosclerosis Kidney Int 48 1995 851 858
35. nd ed), edited by Epstein M, Philadelphia Hanley and Belfus Publishers (in press)
36. K.A. Griffin M.M. Picken A.K. Bidani Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys J Clin Invest 96 1995 793 800
37. E. Perez-Reyes T. Schneider Molecular biology of calcium channels Kidney Int 48 1995 1111 1124
38. G.N. Jyothirmayi A.S. Reddi Effect of diltiazem on glomerular heparan sulfate and albuminuria in diabetic rats Hypertension 216 pt 1 1993 795 802
39. L. Gaber C. Walton S. Brown Bakris GL Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uni-nephrectomized dogs Kidney Int 46 1994 161 169